Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06624696 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia

Study acronym: PEPSI
StatusRecruiting
PhasePhase 4
Started2024-11-12
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 14, 2026 (before its estimated August 31, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-04-09
Study Status, Contacts/Locations v5
Study sitesdetails revised at 1 of 2 sites
2026-03-31
Study Status v4
Primary completion pushed: 2026-06-30 → 2026-08-31
2026-02-02
Study Status v3
Primary completion date2025-09-30→2026-06-30
2025-01-01
Study Identification, Study Status, Study Design, Outcome Measures, Contacts/Locations, References v2
Enrollment target186→204
Study sites1→2
Secondary endpoints12 entries, revised
The incidence and severity of major respiratory adverse events if occurs
Primary endpoints1 entry, revised
The incidence of minor respiratory adverse eventsPRAEs
Publicationsdetails revised at 16 of 17 entries
Study title-3 characters
A Randomized Controlled Study of Inhaling Penehyclidine forto PreventingPrevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia
2024-12-15
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-10-14→confirmed 2024-11-12
Study sites0→1
2024-10-02
Original filing
This randomized controlled study is to evaluate the effectiveness of inhaling penehyclidine hydrochloride in reducing perioperative respiratory adverse events in children at risk undergoing minor elective surgery.
Trial Details
NCT Number NCT06624696
Lead Sponsor Sun Yat-sen University
Collaborators: Shenzhen Eye Hospital
Conditions Respiratory Hypersensitivity, Perioperative Respiratory Adverse Events, Anticholinergics, Inhalation Therapy; Complications, High Risk
Enrollment 204 participants
Start Date 2024-11-12
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-14